The transcription factors SF-1 and WT1 play pivotal roles in mammalian gonadal development and sexual differentiation. In human embryos, both SF-1 and WT1 are expressed when the indifferent gonadal ridge ®rst forms at 32 days post-ovulation. As the sex cords develop ± providing morphological evidence of testis differentiation ± SF-1 localises predominantly to developing Sertoli cells in the sex cords, whereas WT1 retains a broader pattern of expression. Later, SF-1 localises predominantly to steroidogenic Leydig cells, and WT1 localises to the sex cords. In the ovary, SF-1 and WT1 transcripts persist in the gonadal ridge from the earliest developmental stages throughout the critical period of sex determination. These studies, which delineate for the ®rst time the sequential expression pro®les of SF-1 and WT1 during human gonadal development, provide a framework for understanding human sex reversal phenotypes associated with their mutations. q
Results
Based on studies in knockout mice, the transcription factors WT1 and SF-1 play essential roles in mammalian gonadal development and sexual differentiation (Kreidberg et al., 1993; Luo et al., 1994) . In cell transfection studies, these genes regulate production of the critical mediators of male sexual differentiation, Mu Èllerian inhibiting substance (MIS) and testosterone (Parker and Schimmer, 1997; De Santa Barbara et al., 1998; Nachtigal et al. 1998) . Moreover, the sex reversal phenotypes of patients with Denys Drash and Frasier syndromes demonstrate a signi®cant role for WT1 in human sexual differentiation (Pelletier et al., 1991; Barbaux et al., 1997; Kikuchi et al., 1998) . To provide a framework for understanding the roles of WT1 and SF-1 in human gonadal development, we performed in situ hybridisation analyses of sections from precisely staged human embryos (O'Rahilly and Muller, 1987; Bullen and Wilson, 1997) .
In overview, the human gonadal ridge ± containing somatic cells and primordial germ cells ± becomes morphologically distinct on the medial surface of the urogenital ridge at 32 days post-ovulation (dpo; Carnegie stage (CS) 14). During the indifferent gonadal stages, the histology of the urogenital ridge is indistinguishable between males and females. Morphological differentiation of the testis ± presumably induced by upregulation of the male sex-determining gene SRY within the gonadal ridge at 41±44 dpo (CS17-18, manuscript submitted) ± is ®rst evidenced by sex cord formation at 44 dpo/CS18. Sexual differentiation then is mediated by MIS (produced by Sertoli cells in the sex cords) and androgens (produced by Leydig cells in the interstitium). Throughout these stages, the ovary exhibits little histological differentiation.
During the period of the indifferent gonad, WT1 is expressed identically in 46,XY male and 46,XX female embryos. At 32 dpo/CS14, WT1 is expressed at highest levels in the glomerular corpuscles of the mesonephros, and at lower levels in the lining coelomic epithelium and gonadal ridge (Fig. 1) . By 41 dpo/CS17, the mesonephric and coelomic epithelial expression remains unchanged, however the gonadal signal has increased. This signal is identical in males and females, both within transverse sections and throughout the entire gonadal ridge (compare lower panels of Fig. 1 ). This homogenous expression continues throughout early sex cord formation (data not shown). At 52 dpo/CS21, the testicular cords are well advanced indicating that sexual differentiation is underway (Fig. 2 ). Despite this, WT1 expression persists throughout the entire testis, with only the ®rst hint of localisation to the cords. Strong expression also is seen in the lining coelomic epithelium, rete testis, mesonephros, and the developing glomerular structures of the neighbouring metanephros (Fig. 2) . The corresponding ovarian section at 52 dpo/ CS21 lacks morphological differentiation, and WT1 transcripts are generally distributed diffusely throughout the ovary, with increased levels in the rete ovarii (Fig. 3A) . After the embryonic period, WT1 transcripts localise away from the interstitium to the fetal Sertoli cells of the testicular cords, as seen at 18 weeks gestation (Fig. 2) . The more generalised ovarian expression pattern persists in the fetal ovary at 15 weeks gestation (Fig. 3A) .
SF-1 also is expressed from 32 dpo/CS14, initially in a pool of cells medial to the mesonephros and underlying the genital ridge (Fig. 4) . One day later (33 dpo/CS15), there clearly are two discrete sites of SF-1 expression, with significantly higher expression levels from this point onwards in the presumptive adrenal primordium than in the indifferent gonad. Whereas an overlapping expression pattern for WT1 and SF-1 exists within the gonad, no SF-1 expression is seen within the mesonephros and no WT1 expression is seen within the adrenal primordium. By 41 dpo/CS17, the SF-1 signal predominantly localises away from the primordial germ cells, suggesting that these cells do not express SF-1 (Fig. 4C) . Throughout these stages, SF-1 expression is not sexually dimorphic in either gonads or adrenal glands (data not shown). SF-1 remains broadly expressed in the developing testis at 44 dpo/CS18 (Fig. 5A) . Although SF-1 is expressed in the interstitial region at 52 dpo/CS21, the strongest signal at this time is over the sex cords. This corresponds to the increased structural organisation of the cords, with Sertoli cells enveloping the primordial germ cells (see alkaline phosphatase staining in Fig. 5B ). This expression pattern is reversed in the fetal testis at 18 weeks gestation, with relatively greater SF-1 signal over the interstitium than the sex cords (Fig. 5C ). In the developing ovary, in contrast, SF-1 expression more closely parallels that of WT1, with diffuse expression at 52 dpo/CS21 and stronger localisation to the coelomic epithelium later in the fetal period (Fig. 3B) . Interestingly, the persistent SF-1 expression in the developing human ovary apparently differs from the situation in mice and rats, where SF-1 transcripts decrease coincident with sexual differentiation (reviewed by Parker and Schimmer, 1997) .
In summary, these studies provide the ®rst detailed description of the sequential expression pro®les of SF-1 and WT1 during human gonadal development. Knowledge of the expression patterns of WT1 and SF-1 during normal human development will allow increased understanding of potential and documented sex reversal phenotypes caused by their mutation.
Experimental procedures

Human embryo collections
Collection and use of human embryos and fetal material was carried out after ethical permission had been obtained from the Newcastle Health Authority and with the appropriately signed consents (O'Rahilly and Muller, 1987; Bullen and Wilson, 1997) . Fetal material was obtained following second trimester termination. Both embryonic and fetal material was sexed by karyotype analysis.
In situ hybridisation
Riboprobe templates for in situ hybridisation were as follows: SF-1 cDNA, nucleotides 3411-3696 of Genbank Accession no. L08063; WT1 cDNA, nucleotides 1928-2533 of Genbank Accession X51630; MIS cDNA template (EST, Genbank Acc. AA316792), nucleotides 2517-2948 of Genbank Acc. K03474. All cDNA templates were sequenced prior to use. In situ hybridisation was carried out as described previously using [ 35 S] labelled probes on 5 mm thick sections (Lako et al., 1998) . Sections for morphological study were within 10 mm of the corresponding in situ hybridisation analysis. Both SF-1 and WT1 expression was investigated on sections from closely matched 46,XY and 46,XX stages (according to material available) from 32 dpo/ CS14 onwards. 
